China Sexually Transmitted Diseases (STD) Diagnostics Market Size, Share & Trends Analysis Report by Forecast Period 2019-2025

China STD diagnostics market is growing at a CAGR of around 9.5% during the forecast period. China, which is one of the largest developing countries across the globe, has been suffering from the wide-spread of STDs for a long time. Among all of the STDs in China, three are listed as the notifiable infectious diseases, i.e., Gonorrhoea, Syphilis, and HIV/AIDS, which demand more attention, which is influencing the growth of the China STD diagnostics market. Overall, the Yangtze River Delta region, the southwestern border area, and some other border regions are the places demanding more attention.

Get Free Sample link @ https://www.omrglobal.com/request-sample/china-sexually-transmitted-disease-market

The rate of STD in China has recently increased drastically over the years. In China, the high-risk community consists of migrants, workers, prostitutes and their clients, drug users, and homosexuals. Most of the STDs can be treated if it the disease is quickly diagnosed. In China, there are local specialized STD hospitals, including the Shanghai Skin Disease and other large and local hospitals such as Huashan hospital. These hospitals provide STD diagnosis tests across the region. Further, in 2016, the Chinese Centre for Disease Control and Prevention (CCDC) reported 96,000 new HIV cases in the first nine months. China has increased HIV testing efforts and changed its approach depending on the type of group or population being targeted.

A full report of China Sexually Transmitted Diseases (STD) Diagnostics Market available @ https://www.omrglobal.com/industry-reports/china-sexually-transmitted-disease-market

  • Market Coverage
  • Market number available for – 2019-2025
  • Base year- 2019
  • Forecast period- 2020-2025
  • Segment Covered- By Source, By Product Type, By Applications
  • Competitive Landscape- Archer Daniels Midland Co., Ingredion Inc., Kerry Group Plc, Cargill Inc., and others

Market Segmentation

China STD Diagnostics Market by Disease Type

  • Chlamydia
  • Syphilis
  • Gonorrhea
  • Herpes Simplex Virus (HSV)
  • Human Papilloma Virus (HPV)
  • Human Immunodeficiency Virus (HIV)
  • Others

China STD Diagnostics Market by Product

  • Laboratory Testing Devices
  • Point-of-Care (POC) Testing Devices

China STD Diagnostics Market by End-user

  • Hospitals and Clinics
  • Diagnostic Centers
  • Homecare

Company Profiles

  • Abbott Laboratories, Inc.
  • AbbVie Inc.
  • Becton, Dickinson and Co.
  • Biocartis NV
  • Bio-Rad Laboratories, Inc.
  • Danaher Corp.
  • Eli Lilly and Co.
  • Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.

The Report Covers

  • Comprehensive research methodology of the China STD Diagnostics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the China STD Diagnostics market.
  • Insights about market determinants which are stimulating the China STD Diagnostics market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/china-sexually-transmitted-disease-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 780-304-0404